Literature DB >> 33359683

ER stress-induced adipocytes secrete-aldo-keto reductase 1B7-containing exosomes that cause nonalcoholic steatohepatitis in mice.

Huihui Gu1, Kun Yang1, Zhentong Shen1, Kai Jia1, Ping Liu1, Miao Pan1, Chao Sun2.   

Abstract

Nonalcoholic steatohepatitis (NASH) is an increasingly prevalent liver disease linked to obesity and associated complications. Endoplasmic reticulum (ER) stress provokes dysfunction in lipid metabolism, which often leads to a progression of obesity-induced hepatic steatosis to NASH. However, the underlying mechanisms in which ER stress in adipose tissue induces hepatic pathology remain elusive. Here, we used male C57BL/6J mice to develop an animal model of NASH induced by a high fat (HFD) diet and methionine- and choline-deficient (MCD) diets. Using a gene-silencing approach with a recombinant lentiviral vector and extensive LC-MS/MS-based proteomics and lipidomics, we demonstrate that the ER stress-induced adipocyte-secreted exosome (ATEx) orchestrates lipid dynamics in the liver. We also noted that ATEx causes hepatic steatosis, inflammation, and fibrosis that lead to NASH through initial accumulation of glycerol and triglycerides in hepatocytes. We also determined that aldo-keto-reductase 1B7 (Akr1b7), a key mediator in liver lipid metabolism, is involved in ATEx-mediated NASH induction. Of note, Akr1b7 deficiency in ER stress-induced ATEx strongly protected the murine liver against HFD and MCD-induced NASH. Our results indicated that ER stress-induced, adipocyte-secreted ATEx triggers NASH by delivering exosomal AKR1B7 to, and elevating glycerol level, in hepatocytes. These findings suggest potential therapeutic strategie that target ATEx to prevent or manage obesity-induced NASH.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aldo-keto reductase 1B7(Akr1b7); Endoplasmic reticulum stress; Exosomes; Fatty liver; Inflammation; Lipidomics; Metabolic disorder; Nonalcoholic steatohepatitis(NASH); Obesity; Proteomics

Mesh:

Substances:

Year:  2020        PMID: 33359683     DOI: 10.1016/j.freeradbiomed.2020.12.011

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  7 in total

Review 1.  Extracellular vesicles and particles impact the systemic landscape of cancer.

Authors:  Serena Lucotti; Candia M Kenific; Haiying Zhang; David Lyden
Journal:  EMBO J       Date:  2022-09-02       Impact factor: 14.012

Review 2.  Extracellular Vesicles in Pathogenesis and Treatment of Metabolic Associated Fatty Liver Disease.

Authors:  Ji Sun; Dianbao Zhang; Yiling Li
Journal:  Front Physiol       Date:  2022-06-13       Impact factor: 4.755

Review 3.  Integrative biology of extracellular vesicles in diabetes mellitus and diabetic complications.

Authors:  Jing Liu; Yanyan Zhang; Yan Tian; Wei Huang; Nanwei Tong; Xianghui Fu
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

Review 4.  Interactions between endoplasmic reticulum stress and extracellular vesicles in multiple diseases.

Authors:  Jingyao Ye; Xuehong Liu
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

Review 5.  Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies.

Authors:  Tingyu Fang; Hua Wang; Xiaoyue Pan; Peter J Little; Suowen Xu; Jianping Weng
Journal:  Int J Biol Sci       Date:  2022-09-06       Impact factor: 10.750

Review 6.  Neutral sphingomyelinase-2 and cardiometabolic diseases.

Authors:  Sardar Sindhu; Yat Hei Leung; Hossein Arefanian; S R Murthy Madiraju; Fahd Al-Mulla; Rasheed Ahmad; Marc Prentki
Journal:  Obes Rev       Date:  2021-03-18       Impact factor: 9.213

7.  Perturbation of TM6SF2 Expression Alters Lipid Metabolism in a Human Liver Cell Line.

Authors:  Asmita Pant; Yue Chen; Annapurna Kuppa; Xiaomeng Du; Brian D Halligan; Elizabeth K Speliotes
Journal:  Int J Mol Sci       Date:  2021-09-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.